Breaking News Instant updates and real-time market news.

2020-04-22 06:58:15 APLT Applied Therapeutics $35.45 / -4.52 (-11.31%) 06:58 04/22/20 04/22 06:58 04/22/20 06:58	Applied Therapeutics initiated with a Buy at Goldman Sachs Goldman Sachs analyst Paul Choi initiated coverage of Applied Therapeutics with a Buy rating and $60 price target. The company's initial success in galactosemia is a positive indicator for a larger opportunity in diabetic cardiomyopathy, Choi tells investors in a research note. Further, the analyst thinks upcoming clinical and regulatory catalysts for lead asset AT-007 will "further de-risk" the asset in 2020 with a likely launch by 2021.	26 Apr
APLT Applied Therapeutics $35.45 / -4.52 (-11.31%) 02/27/20 Barclays Applied Therapeutics initiated with an Overweight at Barclays 02/27/20 Barclays Applied Therapeutics initiated with an Overweight at Barclays 01/27/20 UBS Applied Therapeutics price target raised to $65 from $20 at UBS 01/09/20 Baird Applied Therapeutics price target raised to $43 from $24 at Baird

2020-04-22 06:58:15

APLT

Applied Therapeutics

$35.45 / -4.52 (-11.31%)

06:58

04/22/20

04/22

06:58

04/22/20

06:58

Applied Therapeutics initiated with a Buy at Goldman Sachs

Goldman Sachs analyst Paul Choi initiated coverage of Applied Therapeutics with a Buy rating and $60 price target. The company's initial success in galactosemia is a positive indicator for a larger opportunity in diabetic cardiomyopathy, Choi tells investors in a research note. Further, the analyst thinks upcoming clinical and regulatory catalysts for lead asset AT-007 will "further de-risk" the asset in 2020 with a likely launch by 2021.

26
Apr

APLT Applied Therapeutics

$35.45 / -4.52 (-11.31%)

02/27/20 Barclays: Applied Therapeutics initiated with an Overweight at Barclays

02/27/20 Barclays: Applied Therapeutics initiated with an Overweight at Barclays

01/27/20 UBS: Applied Therapeutics price target raised to $65 from $20 at UBS

01/09/20 Baird: Applied Therapeutics price target raised to $43 from $24 at Baird

TODAY'S FREE FLY STORIES

General news	5-Yr Note Auction Coupon Rate data reported » 13:10 02/24/21 02/24 13:10 02/24/21 13:10 5-Yr Note Auction Coupon… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
General news	5-Yr Note Auction Total Amount data reported » 13:10 02/24/21 02/24 13:10 02/24/21 13:10 5-Yr Note Auction Total… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Orbcomm price target raised to $9.25 from $7.50 at Roth Capital » 13:09 02/24/21 02/24 13:09 02/24/21 13:09 ORBC Orbcomm $8.02 / +0.405 (+5.32%) Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ORBC Orbcomm $8.02 / +0.405 (+5.32%) 02/11/21 Orbcomm selected by McColl's Transport 12/17/20 Orbcomm extends partnership with Lloyd's List Intelligence 12/11/20 Orbcomm wins $45.6M single-award, multi-year contract from U.S. Army 11/19/20 Ponce uses Orbcomm's satellite IoT technology for agricultural irrigation ORBC Orbcomm $8.02 / +0.405 (+5.32%) 12/21/20 Northland Orbcomm price target raised to $10 from $6 at Northland 07/30/20 Roth Capital Orbcomm price target raised to $7.50 from $7 at Roth Capital 02/27/20 Roth Capital Orbcomm valuation, fundamentals should provide support, says Roth Capital ORBC Orbcomm $8.02 / +0.405 (+5.32%) 07:06 Today Orbcomm sees Q1 revenue $61M-$65M, consensus $62.08M 07:04 Today Orbcomm reports Q4 adjusted EPS (4c), consensus (7c) 10/28/20 Orbcomm sees Q4 revenue $60M-$64M, consensus $63.3M 10/28/20 Orbcomm reports Q3 EPS (7c), consensus (9c) 08:30 Today Orbcomm - ORBC
Recommendations	Credit Agricole price target raised to EUR 13 from EUR 11.50 at RBC Capital » 13:09 02/24/21 02/24 13:09 02/24/21 13:09 CRARY Credit Agricole $0.00 / + (+0.00%) RBC Capital analyst Anke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CRARY Credit Agricole $0.00 / + (+0.00%) 12/15/20 Credit Agricole announces EUR 900M impairment charge for low rates CRARY Credit Agricole $0.00 / + (+0.00%) 05:09 Today JPMorgan Credit Agricole upgraded to Overweight from Neutral at JPMorgan 02/18/21 AlphaValue Credit Agricole upgraded to Add from Sell at AlphaValue 02/12/21 Morgan Stanley Credit Agricole price target raised to EUR 13.10 at Morgan Stanley 01/22/21 Barclays Credit Agricole upgraded to Overweight from Equal Weight at Barclays
Recommendations	TUI AG price target raised to 170 GBp from 68 GBp at UBS » 13:08 02/24/21 02/24 13:08 02/24/21 13:08 TUIFY TUI AG $0.00 / + (+0.00%) UBS analyst Cristian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research TUIFY TUI AG $0.00 / + (+0.00%) 02/12/21 Berenberg TUI AG price target lowered to 175 GBp from 250 GBp at Berenberg 01/27/21 Commerzbank TUI AG downgraded to Reduce from Hold at Commerzbank 01/26/21 HSBC TUI AG downgraded to Reduce from Hold at HSBC 12/21/20 Berenberg TUI AG price target lowered to 250 GBp from 350 GBp at Berenberg

Recommendations	Skanska price target raised to SEK 178 from SEK 172 at UBS » 13:07 02/24/21 02/24 13:07 02/24/21 13:07 SKSBF Skanska $0.00 / + (+0.00%) UBS analyst Anastasia… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SKSBF Skanska $0.00 / + (+0.00%) 01/29/21 Skanska awarded EUR 272M to build new hospital in Finland 01/15/21 Skanska sells office building in Prague for EUR 77M 01/08/21 Skanska signs $392M contract to renovate LIRR concourse in New York 01/07/21 Skanska awarded $56M to construct concourse extension at Atlanta International SKSBF Skanska $0.00 / + (+0.00%) 02/10/21 BofA Skanska downgraded to Underperform from Neutral at BofA 11/20/20 UBS Skanska price target raised to SEK 172 from SEK 160 at UBS 06/08/20 BofA Skanska upgraded to Neutral from Underperform at BofA 05/14/20 UBS Skanska price target lowered to SEK 160 from SEK 175 at UBS
Recommendations	HeidelbergCement price target raised to EUR 73 from EUR 71.50 at UBS » 13:06 02/24/21 02/24 13:06 02/24/21 13:06 HDELY HeidelbergCement $0.00 / + (+0.00%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HDELY HeidelbergCement $0.00 / + (+0.00%) 02/04/21 Goldman Sachs HeidelbergCement downgraded to Sell from Neutral at Goldman Sachs 01/26/21 Deutsche Bank HeidelbergCement price target raised to EUR 82 from EUR 77 at Deutsche Bank 01/22/21 JPMorgan HeidelbergCement price target lowered to EUR 68 from EUR 70 at JPMorgan 01/20/21 Barclays HeidelbergCement price target raised to EUR 74 from EUR 64 at Barclays
Recommendations	Eni SpA price target raised to EUR 11.75 from EUR 11.50 at UBS » 13:05 02/24/21 02/24 13:05 02/24/21 13:05 E Eni SpA $23.35 / +0.21 (+0.91%) UBS analyst Jon Rigby… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research E Eni SpA $23.35 / +0.21 (+0.91%) 02/23/21 Berenberg Eni SpA price target raised to EUR 10 from EUR 9 at Berenberg 02/23/21 DZ Bank Eni SpA upgraded to Hold from Sell at DZ Bank 02/22/21 RBC Capital Eni SpA upgraded to Sector Perform from Underperform at RBC Capital 02/22/21 RBC Capital Eni SpA upgraded to Sector Perform from Underperform at RBC Capital
Options	Applied Materials call volume above normal and directionally bullish » 13:05 02/24/21 02/24 13:05 02/24/21 13:05 AMAT Applied Materials $120.07 / +4.19 (+3.62%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMAT Applied Materials $120.07 / +4.19 (+3.62%) 01/05/21 Applied Materials raises bid for Kokusai Electric to $3.5B 12/08/20 Applied Materials appoints Rani Borkar to its Board of Directors 10/22/20 Applied Materials, Besi enter agreement to develop chip integration technology 09/09/20 Applied Materials announces Growth Technical Advisory Board AMAT Applied Materials $120.07 / +4.19 (+3.62%) 02/19/21 DA Davidson Applied Materials price target raised to $145 from $135 at DA Davidson 02/19/21 JPMorgan Applied Materials price target raised to $146 from $88 at JPMorgan 02/19/21 Craig-Hallum Applied Materials price target raised to $142 from $124 at Craig-Hallum 02/19/21 Evercore ISI Applied Materials price target raised to $140 from $130 at Evercore ISI AMAT Applied Materials $120.07 / +4.19 (+3.62%) 02/18/21 Applied Materials sees Q2 adjusted EPS $1.44-$1.56, consensus $1.28 02/18/21 Applied Materials reports Q1 adjusted EPS $1.39, consensus $1.28 02/18/21 Notable companies reporting after market close 11/12/20 Applied Materials sees Q1 EPS $1.20-$1.32, consensus $1.11 AMAT Applied Materials $120.07 / +4.19 (+3.62%) 10/16/20 China's SAMR may wait until after U.S. election on approvals, Dealreporter says 09/28/20 SMIC, China's biggest chipmaker, facing U.S. sanctions, FT reports 09/03/20 China plans domestic semiconductor overhaul in Trump retaliation, Bloomberg says AMAT Applied Materials $120.07 / +4.19 (+3.62%) 02/18/21 Fly Intel: After-Hours Movers 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 11/12/20 Fly Intel: After-Hours Movers 03/11/21 Applied Materials, Inc. AMAT Applied Materials $120.07 / +4.19 (+3.62%) 02/19/21 Early notable gainers among liquid option names on February 19th 01/14/21 Early notable gainers among liquid option names on January 14th 11/27/20 Early notable gainers among liquid option names on November 27th 11/13/20 Early notable gainers among liquid option names on November 13th
Hot Stocks	ViiV Healthcare submits sNDA to FDA for HIV treatment Cabenuva » 13:05 02/24/21 02/24 13:05 02/24/21 13:05 GSK GlaxoSmithKline $34.60 / +0.23 (+0.67%) , PFE Pfizer $33.81 / -0.09 (-0.27%) ViiV Healthcare, the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSK PFE GSK GlaxoSmithKline $34.60 / +0.23 (+0.67%) 02/22/21 Sanofi, GSK initiate Phase 2 study of COVID-19 vaccine candidate 02/17/21 GlaxoSmithKline, Vir expand coronavirus collaboration for respiratory viruses 02/05/21 CureVac enters pact with UK Government to develop SARS-CoV-2 variant vaccine 02/03/21 GlaxoSmithKline sees 'meaningful' improvement in revenues, margins in 2022 PFE Pfizer $33.81 / -0.09 (-0.27%) 08:11 Today Pfizer, Seven Bridges form partnership 02/23/21 Pfizer's application for TicoVac accepted by FDA for priority review 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony 02/22/21 Amyris announces pre-clinical results for COVID RNA vaccine platform GSK PFE GSK GlaxoSmithKline $34.60 / +0.23 (+0.67%) 02/12/21 Morgan Stanley GlaxoSmithKline price target lowered to 1,580 GBp at Morgan Stanley 02/11/21 Berenberg GlaxoSmithKline price target lowered to 1,570 GBp from 1,720 GBp at Berenberg 02/09/21 JPMorgan GlaxoSmithKline price target lowered to 1,300 GBp from 1,500 GBp at JPMorgan 02/08/21 UBS GlaxoSmithKline price target lowered to 1,320 GBp from 1,450 GBp at UBS PFE Pfizer $33.81 / -0.09 (-0.27%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/10/21 KeyBanc Maravai Lifesciences price target raised to $39 from $33 at KeyBanc 02/04/21 DZ Bank Pfizer upgraded to Buy from Hold at DZ Bank 02/03/21 Mizuho Pfizer price target lowered to $42 from $44 at Mizuho GSK PFE GSK GlaxoSmithKline $34.60 / +0.23 (+0.67%) 02/03/21 GlaxoSmithKline reports Q4 adjusted EPS 23.3p vs. 24.8p a year ago 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% PFE Pfizer $33.81 / -0.09 (-0.27%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open GSK PFE GSK GlaxoSmithKline $34.60 / +0.23 (+0.67%) 02/09/21 Teva wins new hearing on $235M GSK patent verdict, Bloomberg reports 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says PFE Pfizer $33.81 / -0.09 (-0.27%) 02/19/21 Pfizer to use additional capacity to boost vaccine output, Bloomberg says 02/19/21 BioNTech, Pfizer vaccine 85% effective after first dose, FT reports 02/17/21 Moderna to supply EU with another 150M vaccine doses in 2021, FT reports 02/14/21 Study finds 94% drop in symptomatic COVID cases with Pfizer vaccine,Reuters says GSK PFE GSK GlaxoSmithKline $34.60 / +0.23 (+0.67%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/17/21 Fly Intel: Pre-market Movers 02/11/21 Fly Intel: Wall Street's top stories for Thursday PFE Pfizer $33.81 / -0.09 (-0.27%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 02/18/21 Fly Intel: Wall Street's top stories for Thursday 02/18/21 Fly Intel: Wall Street's top stories at midday 02/23/21 10th Annual Global Healthcare Virtual Conference 02/27/21 AAAAI Virtual Annual Meeting 2021 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 03/24/21 Arthritis Advisory Committee and Drug Safety & Risk Mgmt Committee Meeting 03/24/21 Joint Committee Virtual Meeting 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 03/05/21 Pfizer GSK PFE GSK GlaxoSmithKline $34.60 / +0.23 (+0.67%) 09/04/20 GlaxoSmithKline call volume above normal and directionally bullish PFE Pfizer $33.81 / -0.09 (-0.27%) 01/29/21 Unusually active option classes on open January 29th 01/25/21 Pfizer call volume above normal and directionally bullish 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th

Hot Stocks	Walgreens says Pixel by Labcorp COVID-19 PCR test to be available OTC nationwide » 13:03 02/24/21 02/24 13:03 02/24/21 13:03 WBA Walgreens Boots Alliance $48.98 / +0.56 (+1.16%) , LH LabCorp $243.40 / -3.83 (-1.55%) Walgreens (WBA) has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options WBA LH WBA Walgreens Boots Alliance $48.98 / +0.56 (+1.16%) 08:07 Today CRL makes first at-home COVID-19 saliva test available through Walgreens 02/23/21 Walgreens launches rollout of same-day delivery with Instacart 02/19/21 Walgreens provides over 3M COVID-19 vaccinations 02/17/21 SmileDirectClub announces Walgreens as retail partner LH LabCorp $243.40 / -3.83 (-1.55%) 02/23/21 Adaptive Biotechnologies expands collaboration with LabCorp 02/18/21 Pacific Biosciences announces LabCorp's addition of PacBio Sequel II Systems 02/17/21 LabCorp adds antigen test for COVID-19 infection screening 02/16/21 Jana Partners buys TreeHouse Foods, exits Callaway in Q4 WBA LH WBA Walgreens Boots Alliance $48.98 / +0.56 (+1.16%) 01/27/21 Deutsche Bank Walgreens Boots Alliance price target raised to $49 from $44 at Deutsche Bank 01/15/21 Baird Walgreens Boots Alliance price target raised to $64 from $55 at Baird 01/11/21 Fly Intel: Top five analyst upgrades 01/11/21 Baird Baird upgrades Walgreens Boots Alliance following Q1 results LH LabCorp $243.40 / -3.83 (-1.55%) 02/12/21 JPMorgan LabCorp price target raised to $279 from $261 at JPMorgan 02/12/21 Mizuho LabCorp price target raised to $267 from $242 at Mizuho 02/12/21 Citi LabCorp price target raised to $278 from $257 at Citi 01/29/21 Citi LabCorp price target raised to $257 from $249 at Citi WBA LH WBA Walgreens Boots Alliance $48.98 / +0.56 (+1.16%) 01/07/21 Walgreens Boots Alliance backs FY21 adjusted EPS view up low single digits 01/07/21 Walgreens Boots Alliance reports Q1 adjusted EPS $1.22, consensus $1.03 01/06/21 Notable companies reporting before tomorrow's open 01/06/21 Notable companies reporting before tomorrow's open LH LabCorp $243.40 / -3.83 (-1.55%) 02/11/21 LabCorp sees FY21 adjusted EPS $19.00-$23.00, consensus $20.14 02/11/21 LabCorp reports Q4 adjusted EPS $10.56, consensus $8.11 10/27/20 LabCorp continues to not provide 2020 guidance 10/27/20 LabCorp reports Q3 adjusted EPS $8.41, consensus $5.25 WBA LH WBA Walgreens Boots Alliance $48.98 / +0.56 (+1.16%) 02/14/21 Walmart COVID vaccine rollout heading to small towns, WSJ reports 01/26/21 Walgreens Boots Alliance set to name Starbucks COO Roz Brewer as CEO, WSJ says 01/26/21 Walgreens to name Starbucks executive Roz Brewer as CEO, WSJ says 12/20/20 CDC panel says frontline workers, people over 74 should be next, NYTimes reports LH LabCorp $243.40 / -3.83 (-1.55%) 02/23/21 Jana Partners nominates directors to LabCorp board, Reuters reports 02/23/21 LabCorp higher after Bloomberg says Jana nominated directors 02/23/21 Jana Partners nominated directors to LabCorp board, Bloomberg reports 01/12/21 LabCorp CEO: COVID vaccine recipients don't need antibody test after, CNBC says WBA LH WBA Walgreens Boots Alliance $48.98 / +0.56 (+1.16%) 01/27/21 Fly Intel: Wall Street's top stories for Wednesday 01/27/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: After-Hours Movers 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street LH LabCorp $243.40 / -3.83 (-1.55%) 02/23/21 Fly Intel: Wall Street's top stories for Tuesday 02/23/21 Fly Intel: Wall Street's top stories at midday 08/27/20 Abbott Labs jumps after securing FDA approval for $5 COVID-19 test WBA LH WBA Walgreens Boots Alliance $48.98 / +0.56 (+1.16%) 02/09/21 Walgreen Boots call volume above normal and directionally bullish 01/29/21 Walgreen Boots call volume above normal and directionally bullish 01/11/21 Early notable gainers among liquid option names on January 11th 12/31/20 Walgreen Boots call volume above normal and directionally bullish LH LabCorp $243.40 / -3.83 (-1.55%) 02/17/21 Early notable gainers among liquid option names on February 17th 10/27/20 Early notable gainers among liquid option names on October 27th 10/16/20 Early notable gainers among liquid option names on October 16th
Hot Stocks	Carnival extends pause from U.S. through May 2021 » 13:02 02/24/21 02/24 13:02 02/24/21 13:02 CCL Carnival $27.50 / +1.04 (+3.93%) Carnival Cruise Line has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Periodicals On The Fly Options CCL Carnival $27.50 / +1.04 (+3.93%) 02/22/21 Carnival falls 3% to $25.27 after $1B equity offering 02/17/21 Carnival's Michael Thamm sells over $472K in company shares 02/17/21 Carnival to restart Italian cruises through Costa Cruises in March 01/26/21 BioHiTech Global receives $2M in purchase orders for Carnival ships CCL Carnival $27.50 / +1.04 (+3.93%) 02/12/21 Berenberg Carnival downgraded to Sell from Hold at Berenberg 01/26/21 HSBC Carnival downgraded to Reduce from Hold at HSBC 01/22/21 Truist Carnival price target raised to $14 from $11 at Truist 01/12/21 Deutsche Bank Carnival price target raised to $16 from $13 at Deutsche Bank 23 Feb 02 Apr CCL Carnival $27.50 / +1.04 (+3.93%) 01/11/21 Carnival tells WSJ Q4 sales in tens of millions, consensus $156M 11/13/20 Five people aboard SeaDream cruise ship test positive for COVID, CNN reports 09/30/20 White House planning meeting with cruise line CEOs for Friday, CNBC says 09/30/20 CDC Director Redfield overruled on cruise ship 'no-sail order,' Axios reports CCL Carnival $27.50 / +1.04 (+3.93%) 02/22/21 Fly Intel: After-Hours Movers 11/09/20 Fly Intel: Wall Street's top stories at midday 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 11/09/20 Fly Intel: Pre-market Movers CCL Carnival $27.50 / +1.04 (+3.93%) 02/22/21 Carnival call volume above normal and directionally bullish 02/19/21 Carnival call volume above normal and directionally bullish 02/19/21 Early notable gainers among liquid option names on February 19th 02/16/21 Carnival call volume above normal and directionally bullish
Syndicate	Mogo announces closing of $54M registered direct offering priced at-the-market » 13:01 02/24/21 02/24 13:01 02/24/21 13:01 MOGO Mogo $8.13 / +1.02 (+14.35%) Mogo announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research MOGO Mogo $8.13 / +1.02 (+14.35%) 02/01/21 Mogo reports over 300% increase in bitcoin transaction volume in January 01/04/21 Mogo reports 108% increase in new bitcoin accounts in December vs. November 12/23/20 Mogo to make corporate investment in bitcoin 12/14/20 Mogo receives TSX approval related to acquisition of Carta Solutions MOGO Mogo $8.13 / +1.02 (+14.35%) 02/11/21 Canaccord Mogo downgraded to Hold from Speculative Buy at Canaccord 01/08/21 Raymond James Mogo price target raised to C$7.50 from C$4.50 at Raymond James 12/01/20 Raymond James Mogo price target raised to C$4.50 from C$4 at Raymond James 11/23/20 H.C. Wainwright Mogo initiated with a Buy at H.C. Wainwright
Recommendations	Rightmove price target raised to 600 GBp from 540 GBp at Deutsche Bank » 13:01 02/24/21 02/24 13:01 02/24/21 13:01 RTMVY Rightmove $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research RTMVY Rightmove $0.00 / + (+0.00%) 02/04/21 UBS Rightmove price target raised to 630 GBp from 620 GBp at UBS 01/29/21 Barclays Rightmove price target lowered to 550 GBp from 575 GBp at Barclays 01/20/21 BofA Rightmove downgraded to Underperform from Neutral at BofA 01/12/21 Berenberg Rightmove price target raised to 440 GBp from 400 GBp at Berenberg
Recommendations	InterContinental price target lowered to 5,380 GBp at Deutsche Bank » 12:59 02/24/21 02/24 12:59 02/24/21 12:59 IHG InterContinental $73.13 / -0.92 (-1.24%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research IHG InterContinental $73.13 / -0.92 (-1.24%) 09/18/20 InterContinental falls -4.2% 09/18/20 InterContinental falls -4.3% 08/25/20 Service Properties to transfer 103 hotels to Sonesta from InterContinental IHG InterContinental $73.13 / -0.92 (-1.24%) 05:11 Today Deutsche Bank InterContinental downgraded to Hold from Buy at Deutsche Bank 02/22/21 Peel Hunt InterContinental downgraded to Reduce from Hold at Peel Hunt 02/18/21 Morgan Stanley InterContinental price target raised to 4,600 GBp from 4,300 GBp at Morgan Stanley 02/12/21 Berenberg InterContinental price target raised to 4,500 GBp from 4,000 GBp at Berenberg

Recommendations	Covestro price target raised to EUR 76 from EUR 65 at Deutsche Bank » 12:58 02/24/21 02/24 12:58 02/24/21 12:58 COVTY Covestro $0.00 / + (+0.00%) Deutsche Bank analyst Tim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals COVTY Covestro $0.00 / + (+0.00%) 01/13/21 Berenberg Covestro price target raised to EUR 60 from EUR 47 at Berenberg 01/12/21 Barclays Covestro price target raised to EUR 64 from EUR 53 at Barclays 12/17/20 UBS Covestro price target raised to EUR 45 from EUR 41 at UBS 12/14/20 Morgan Stanley Covestro price target raised to EUR 60 from EUR 55 at Morgan Stanley COVTY Covestro $0.00 / + (+0.00%) 09/17/20 Apollo exploring takeover of Covestro, Bloomberg reports 09/17/20 Apollo Global said to weigh takeover of Covestro, Bloomberg reports
General news	Fed Chair Powell is pushing back against criticism that the Fed's QE purchases » 12:55 02/24/21 02/24 12:55 02/24/21 12:55 Fed Chair Powell is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Conference/Events	Marcus & Millichap to host virtual investor meeting » 12:55 02/24/21 02/24 12:55 02/24/21 12:55 MMI Marcus & Millichap $39.48 / -0.06 (-0.15%) Virtual Investor Meeting… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events MMI Marcus & Millichap $39.48 / -0.06 (-0.15%) 02/18/21 Marcus & Millichap says 'disruptive nature' of Covid diminishing 12/21/20 Marcus & Millichap acquires LMI Capital, terms not disclosed 10/19/20 Marcus & Millichap to acquire Mission Capital 09/23/20 Marcus & Millichap division sells multifamily asset in Phoenix for $90M MMI Marcus & Millichap $39.48 / -0.06 (-0.15%) 04/09/20 Wells Fargo Marcus & Millichap downgraded at Wells Fargo on declining transaction volume 04/09/20 Wells Fargo Marcus & Millichap downgraded to Underweight from Equal Weight at Wells Fargo MMI Marcus & Millichap $39.48 / -0.06 (-0.15%) 02/18/21 Marcus & Millichap reports Q4 EPS 59c, consensus 15c MMI Marcus & Millichap $39.48 / -0.06 (-0.15%) 02/18/21 Fly Intel: After-Hours Movers 00:00 Today 24th Annual Real Estate Securities Virtual Conference 13:00 Today Marcus & Millichap
Syndicate	American National Bankshares files $75M mixed securities shelf 12:54 02/24/21 02/24 12:54 02/24/21 12:54 AMNB American National Bankshares $31.17 / +0.92 (+3.04%) ShowHide Related Items >><< Company News Street Research Earnings AMNB American National Bankshares $31.17 / +0.92 (+3.04%) 01/11/21 American National Bankshares authorizes up to 350,000 share repurchase program AMNB American National Bankshares $31.17 / +0.92 (+3.04%) 04/29/20 Stephens American National Bankshares upgraded to Overweight from Equal Weight at Stephens AMNB American National Bankshares $31.17 / +0.92 (+3.04%) 01/21/21 American National Bankshares reports Q4 EPS 80c, consensus 69c 10/22/20 American National Bankshares reports Q3 EPS 66c, consensus 56c
Upgrade	Barrington upgrades Heidrick & Struggles to Outperform, sees continued recovery » 12:50 02/24/21 02/24 12:50 02/24/21 12:50 HSII Heidrick & Struggles $37.36 / +1.08 (+2.98%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly HSII Heidrick & Struggles $37.36 / +1.08 (+2.98%) 02/01/21 Heidrick & Struggles appoints Kaman Coar as chief inclusion officer 10/26/20 Heidrick & Struggles CEO sees 'an acceleration in our business' HSII Heidrick & Struggles $37.36 / +1.08 (+2.98%) 12:47 Today Barrington Heidrick & Struggles upgraded to Outperform from Market Perform at Barrington 02/23/21 Truist Heidrick & Struggles price target raised to $40 from $25 at Truist 04/29/20 Barrington Heidrick & Struggles downgraded to Market Perform from Outperform at Barrington HSII Heidrick & Struggles $37.36 / +1.08 (+2.98%) 02/23/21 Heidrick & Struggles sees Q1 revenue $160M-$170M, consensus $142.1M 02/22/21 Heidrick & Struggles reports Q4 adjusted EPS 59c, consensus 31c 10/26/20 Heidrick & Struggles sees Q4 revenue $140M-$150M, consensus $141.3M 10/26/20 Heidrick & Struggles reports Q3 adjusted EPS 39c, consensus (36c) HSII Heidrick & Struggles $37.36 / +1.08 (+2.98%) 02/22/21 Fly Intel: After-Hours Movers

Upgrade	Heidrick & Struggles upgraded to Outperform from Market Perform at Barrington » 12:47 02/24/21 02/24 12:47 02/24/21 12:47 HSII Heidrick & Struggles $37.36 / +1.08 (+2.98%) Barrington analyst Kevin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly HSII Heidrick & Struggles $37.36 / +1.08 (+2.98%) 02/01/21 Heidrick & Struggles appoints Kaman Coar as chief inclusion officer 10/26/20 Heidrick & Struggles CEO sees 'an acceleration in our business' HSII Heidrick & Struggles $37.36 / +1.08 (+2.98%) 02/23/21 Truist Heidrick & Struggles price target raised to $40 from $25 at Truist 04/29/20 Barrington Heidrick & Struggles downgraded to Market Perform from Outperform at Barrington HSII Heidrick & Struggles $37.36 / +1.08 (+2.98%) 02/23/21 Heidrick & Struggles sees Q1 revenue $160M-$170M, consensus $142.1M 02/22/21 Heidrick & Struggles reports Q4 adjusted EPS 59c, consensus 31c 10/26/20 Heidrick & Struggles sees Q4 revenue $140M-$150M, consensus $141.3M 10/26/20 Heidrick & Struggles reports Q3 adjusted EPS 39c, consensus (36c) HSII Heidrick & Struggles $37.36 / +1.08 (+2.98%) 02/22/21 Fly Intel: After-Hours Movers
Options	Halliburton call volume above normal and directionally bullish » 12:45 02/24/21 02/24 12:45 02/24/21 12:45 HAL Halliburton $22.19 / +1.25 (+5.97%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options HAL Halliburton $22.19 / +1.25 (+5.97%) 02/17/21 Halliburton appoints Bob Patel to board of directors 02/03/21 Halliburton awarded contract from Kuwait Oil Company 01/19/21 Halliburton expects free cash flow to 'more than double' in 2021 01/19/21 Halliburton sees global supply, demand in balance in 2022 HAL Halliburton $22.19 / +1.25 (+5.97%) 02/01/21 Fly Intel: Top five analyst upgrades 02/01/21 Piper Sandler Halliburton upgraded to Overweight from Neutral at Piper Sandler 01/27/21 Evercore ISI Evercore upgrades NexTier Oilfield to Outperform on tightening market conditions 01/25/21 Atlantic Equities Halliburton upgraded to Overweight from Neutral at Atlantic Equities HAL Halliburton $22.19 / +1.25 (+5.97%) 01/19/21 Halliburton reports Q4 adjusted EPS 18c, consensus 15c 10/19/20 Halliburton reports Q3 adjusted EPS 11c, consensus 8c HAL Halliburton $22.19 / +1.25 (+5.97%) 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says 10/27/20 President Trump weighing executive order to show support for fracking, WSJ says HAL Halliburton $22.19 / +1.25 (+5.97%) 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Pre-market Movers 10/31/20 Week in review: How Trump's policies moved stocks 03/01/21 26th Annual Energy Virtual Summit 05/19/21 Halliburton Company HAL Halliburton $22.19 / +1.25 (+5.97%) 02/22/21 Halliburton call volume above normal and directionally bullish 01/22/21 Halliburton call volume above normal and directionally bullish 12/11/20 Halliburton put volume heavy and directionally bearish 12/04/20 Halliburton call volume above normal and directionally bullish
Conference/Events	Oppenheimer healthcare analysts hold an analyst/industry conference call » 12:42 02/24/21 02/24 12:42 02/24/21 12:42 Healthcare Analysts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Periodicals	Estee Lauder to close down Becca brand, WWD reports » 12:41 02/24/21 02/24 12:41 02/24/21 12:41 EL Estee Lauder $296.01 / +4.15 (+1.42%) As part of Estee… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options EL Estee Lauder $296.01 / +4.15 (+1.42%) 02/23/21 Estee Lauder to increase ownership in DECIEM Beauty Group from 29% to 76% 02/05/21 Estee Lauder CEO: We have a great strategy and it's working 02/05/21 Estee Lauder not providing EPS, sales guidance for FY21 02/05/21 Estee Lauder plans to resume share repurchases in 2H21 EL Estee Lauder $296.01 / +4.15 (+1.42%) 09:02 Today DA Davidson Estee Lauder price target raised to $348 from $320 at DA Davidson 07:23 Today Deutsche Bank Estee Lauder price target raised to $316 from $307 at Deutsche Bank 02/22/21 Morgan Stanley Estee Lauder price target raised to $331 from $312 at Morgan Stanley 02/09/21 RBC Capital Estee Lauder price target raised to $314 from $271 at RBC Capital EL Estee Lauder $296.01 / +4.15 (+1.42%) 02/05/21 Estee Lauder reports Q2 adjusted EPS $2.61, consensus $1.69 02/05/21 Estee Lauder sees Q3 adjusted EPS $1.10-$1.20, consensus $1.46 02/05/21 Estee Lauder reports Q2 diluted EPS $2.37, consensus $1.69 02/04/21 Notable companies reporting before tomorrow's open EL Estee Lauder $296.01 / +4.15 (+1.42%) 02/08/21 Estee Lauder rises as analysts say buy on strong quarter, pivot to digital 02/08/21 Target, Estee Lauder upgrades among today's top calls on Wall Street 02/05/21 Fly Intel: Pre-market Movers 11/23/20 Fly Insider: Organogenesis, Estee Lauder among weeks notable insider trades 05/03/21 Estee Lauder - EL EL Estee Lauder $296.01 / +4.15 (+1.42%) 02/05/21 Early notable gainers among liquid option names on February 5th
Periodicals	Euro Tech Holdings unit awarded sales order in Jiangsu, Euro Tech reports » 12:41 02/24/21 02/24 12:41 02/24/21 12:41 CLWT Euro Tech Holdings $6.25 / +0.64 (+11.41%) Euro Tech Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News CLWT Euro Tech Holdings $6.25 / +0.64 (+11.41%) 01/26/21 Euro Tech Holdings says PACT awarded 'newly revised' IMO G8 certificate 10/09/20 Euro Tech Holdings receives $440,000 letter of award from Shanghai port client

Events

Earnings calls, analyst events, roadshows and more

VER
Today at 13:30

Vereit - VER Conference Calls
CMTOY
Today at 14:00

Cementos Argos - CMTOY Conference Calls
NBR
Today at 14:00

Nabors Industries - NBR Conference Calls
BCPC
Today at 14:00

Balchem - BCPC Conference Calls
WES
Today at 14:00

Western Midstream - WES Conference Calls
CLDT
Today at 14:00

Chatham Lodging - CLDT Conference Calls
CMBM
Today at 14:00

Cambium Networks Firm Sponsored Meetings

Virtual Evemt
MAT
Today at 15:00

Mattel - MAT Conference Calls
VIACA
Today at 16:15

ViacomCBS - VIACA Conference Calls
VIAC
Today at 16:15

ViacomCBS - VIAC Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	OUT X OUT Outfront Media Block Trade Managers: Morgan Stanley Priced at: $22.00 1.76M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BWAY X BWAY Brainsway Spot Secondary Managers: Oppenheimer Priced at: $8.50 4.62M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CCL X CCL Carnival Spot Secondary Managers: Goldman Sachs Priced at: $25.10 40.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PAVM X PAVM PAVmed Spot Secondary Managers: Cantor Fitzgerald Priced at: $4.60 9.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SHOP X SHOP Shopify Spot Secondary Managers: Citi, Credit Suisse & Goldman Sachs Priced at: $1,315 1.18M Shares
Tues	DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse Priced at: $42.70 11M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BCTX X BCTX BriaCell IPO Managers: ThinkEquity Priced at: $4.25 5.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BFRA X BFRA Biofrontera Secondary Managers: Benchmark, LAKE Priced at: $6.68 1.334M Shares FRPT X FRPT Freshpet Secondary Managers: BofA, Baird & Truist Priced at: $143.00 2.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CELC X CELC Celcuity Spot Secondary Managers: Craig-Hallum Priced at: $14.00 1.714M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	SCR X SCR Score Media Secondary Managers: Morgan Stanley, Credit Suisse, Canaccord & Macquarie $36.50 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TROX X TROX Tronox Secondary Managers: JPMorgan, BofA, Deutsche Bank, Morgan Stanley $20.12 17M Shares
Thurs	GTES X GTES Gates Industrial Secondary Managers: Citi & Evercore ISI, Barclays, Credit Suisse, Goldman Sachs, Morgan Stanley, RBC Capital, UBS, Baird, Nomura, Wells Fargo, Guggenheim, KeyBanc $17.87 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Applied Therapeutics initiated with a Buy at Goldman Sachs

TODAY'S FREE FLY STORIES

Get Full Fly Access